U.K. Regulator to Probe Roche's Acquisition of Spark Therapeutics
25 Septembre 2019 - 8:54AM
Dow Jones News
By Kim Richters
The U.K. Competition and Markets Authority is reviewing Roche
Holding AG's (RO.EB) planned acquisition of Spark Therapeutics Inc.
(ONCE), the regulator said Wednesday.
Swiss pharmaceuticals company Roche announced plans to acquire
U.S.-based biotechnology company Sparks in February this year.
The authority is considering whether a merger would lead to a
substantial lessening of competition within the United Kingdom and
it seeks comments on the deal by Oct. 11, it said.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
September 25, 2019 02:39 ET (06:39 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Onconetix (NASDAQ:ONCE)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Onconetix (NASDAQ:ONCE)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025
